Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Boletín médico del Hospital Infantil de México
versión impresa ISSN 1665-1146
Resumen
OVIEDO, Norma; MANUEL-APOLINAR, Leticia; DE LA CHESNAYE, Elsa y GUERRA-ARAIZA, Christian. Genetic and neuroendocrine aspects in autism spectrum disorder. Bol. Med. Hosp. Infant. Mex. [online]. 2015, vol.72, n.1, pp.5-14. ISSN 1665-1146. https://doi.org/10.1016/j.bmhimx.2015.01.010.
The autism spectrum disorder (ASD) was described in 1943 and is defined as a developmental disorder that affects social interaction and communication. It is usually identified in early stages of development from 18 months of age. Currently, autism is considered a neurological disorder with a spectrum covering cases of different degrees, which is associated with genetic factors, not genetic and environmental. Among the genetic factors, various syndromes have been described that are associated with this disorder. Also, the neurobiology of autism has been studied at the genetic, neurophysiological, neurochemical and neuropathological levels. Neuroimaging techniques have shown multiple structural abnormalities in these patients. There have also been changes in the serotonergic, GABAergic, catecholaminergic and cholinergic systems related to this disorder. This paper presents an update of the information presented in the genetic and neuroendocrine aspects of autism spectrum disorder.
Palabras llave : Autism; Autism spectrum; Autism genetics; Syndromic autism.